CA2867511A1 - Method of treatment of wrinkles using topical chemodenervating agents - Google Patents

Method of treatment of wrinkles using topical chemodenervating agents Download PDF

Info

Publication number
CA2867511A1
CA2867511A1 CA2867511A CA2867511A CA2867511A1 CA 2867511 A1 CA2867511 A1 CA 2867511A1 CA 2867511 A CA2867511 A CA 2867511A CA 2867511 A CA2867511 A CA 2867511A CA 2867511 A1 CA2867511 A1 CA 2867511A1
Authority
CA
Canada
Prior art keywords
botulinum toxin
gly
positively charged
wrinkles
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2867511A
Other languages
English (en)
French (fr)
Inventor
Jacob M. Waugh
L. Daniel Browne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revance Therapeuticals Inc
Original Assignee
Revance Therapeuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Revance Therapeuticals Inc filed Critical Revance Therapeuticals Inc
Publication of CA2867511A1 publication Critical patent/CA2867511A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Biotechnology (AREA)
CA2867511A 2012-03-22 2013-03-22 Method of treatment of wrinkles using topical chemodenervating agents Abandoned CA2867511A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261614206P 2012-03-22 2012-03-22
US61/614,206 2012-03-22
PCT/US2013/033417 WO2013142755A1 (en) 2012-03-22 2013-03-22 Method of treatment of wrinkles using topical chemodenervating agents

Publications (1)

Publication Number Publication Date
CA2867511A1 true CA2867511A1 (en) 2013-09-26

Family

ID=49212026

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2867511A Abandoned CA2867511A1 (en) 2012-03-22 2013-03-22 Method of treatment of wrinkles using topical chemodenervating agents

Country Status (11)

Country Link
US (2) US20130251770A1 (enExample)
EP (2) EP3103472A1 (enExample)
JP (1) JP2015514074A (enExample)
KR (1) KR20140139010A (enExample)
CN (1) CN104602703A (enExample)
AU (1) AU2013234988A1 (enExample)
BR (1) BR112014023244A2 (enExample)
CA (1) CA2867511A1 (enExample)
HK (1) HK1207007A1 (enExample)
MX (1) MX2014011376A (enExample)
WO (1) WO2013142755A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070110402A (ko) * 2005-03-03 2007-11-16 레반스 테라퓨틱스 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법
US9486408B2 (en) * 2005-12-01 2016-11-08 University Of Massachusetts Lowell Botulinum nanoemulsions
EP3760186A1 (en) * 2014-04-30 2021-01-06 Allergan, Inc. Formulations of biologics for intravesical instillation
CN109069608A (zh) 2015-10-29 2018-12-21 雷文斯治疗公司 具有长的治疗或美容效应持续时间的可注射肉毒杆菌毒素制剂以及其使用方法
EP3541358A1 (en) 2016-11-21 2019-09-25 Eirion Therapeutics, Inc. Transdermal delivery of large agents
WO2020056191A1 (en) 2018-09-13 2020-03-19 Eirion Therapeutics, Inc. Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors
WO2020069222A1 (en) * 2018-09-26 2020-04-02 Global Health Solutions Llc Topical neurotoxin compositions
KR20200080179A (ko) 2018-12-26 2020-07-06 아미코젠주식회사 아세틸콜린 수용체 저해 펩타이드 및 이의 용도
EP4393502A2 (en) 2018-12-26 2024-07-03 Skinmed Co., Ltd. Acetylcholine receptor inhibitory peptides and uses thereof
KR20230017747A (ko) 2021-07-27 2023-02-06 주식회사 스킨메드 아세틸콜린 수용체 결합 최적화 단축 펩타이드 및 이의 용도
EP4378950A4 (en) 2021-07-27 2025-10-15 Skinmed Co Ltd OPTIMIZED SHORTENED PEPTIDE THAT BINDS TO THE ACETYLCHOLINE RECEPTOR, AND ITS USE

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877278A (en) 1992-09-24 1999-03-02 Chiron Corporation Synthesis of N-substituted oligomers
US5632731A (en) * 1994-11-25 1997-05-27 The Kendall Company Non-adherent wound dressing
US6444209B1 (en) 1996-10-28 2002-09-03 Wisconsin Alumni Research Foundation Hybrid botulinal neurotoxins
US7276246B2 (en) * 2003-05-09 2007-10-02 Cephalon, Inc. Dissolvable backing layer for use with a transmucosal delivery device
HUE025656T2 (en) * 2004-03-03 2016-04-28 Revance Therapeutics Inc Topical application and transdermal delivery of botulinum toxins
BRPI0508440A (pt) * 2004-03-03 2007-07-24 Revance Therapeutics Inc composições e métodos para diagnóstico tópico e transporte terapêutico
US20050220821A1 (en) * 2004-03-31 2005-10-06 Allergan, Inc. Pressure sore treatment
JP2005306746A (ja) * 2004-04-19 2005-11-04 Jiyugaoka Clinic 顔面用シワ治療剤
EP1796676B1 (en) * 2004-05-07 2016-03-09 Phytotox Limited Transdermal administration of phycotoxins
US7838011B2 (en) 2005-02-14 2010-11-23 Pankaj Modi Stabilized protein compositions for topical administration and methods of making same
KR20070110402A (ko) * 2005-03-03 2007-11-16 레반스 테라퓨틱스 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및방법
WO2007059528A2 (en) 2005-11-17 2007-05-24 Revance Therapeutics, Inc. Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
PL3144013T3 (pl) 2005-12-01 2019-04-30 Univ Of Massachusetts Lowell Nanoemulsje botulinowe
WO2008082889A2 (en) * 2006-12-29 2008-07-10 Revance Therapeutics, Inc. Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from hiv-tat
US20100050075A1 (en) 2008-08-22 2010-02-25 Lennox Manufacturing, Inc., A Corporation Of Delaware Display apparatus and method for a control unit for an environmental control system
CN102869373B (zh) 2009-06-25 2017-05-10 雷文斯治疗公司 不含白蛋白的肉毒杆菌毒素制剂
BR112012010058A2 (pt) * 2009-10-30 2016-05-31 Duoject Inc aplicador tópico para um agente paralítico e método para aplicação do agente
ES3036435T3 (en) * 2011-01-07 2025-09-18 Revance Therapeutics Inc Kits for topical application, removal, and inactivation of therapeutic or cosmetic botulinum toxin compositions

Also Published As

Publication number Publication date
WO2013142755A1 (en) 2013-09-26
KR20140139010A (ko) 2014-12-04
HK1207007A1 (en) 2016-01-22
US20130251770A1 (en) 2013-09-26
EP2841095A1 (en) 2015-03-04
MX2014011376A (es) 2014-10-14
AU2013234988A1 (en) 2014-10-09
CN104602703A (zh) 2015-05-06
EP3103472A1 (en) 2016-12-14
US20170157020A1 (en) 2017-06-08
EP2841095A4 (en) 2016-01-13
JP2015514074A (ja) 2015-05-18
BR112014023244A2 (pt) 2017-07-18

Similar Documents

Publication Publication Date Title
US20170157020A1 (en) Method of treatment of wrinkles using topical chemodenervating agents
JP6976997B2 (ja) 注射用ボツリヌス毒素製剤
ES2907652T3 (es) Formulaciones inyectables de toxina botulínica y métodos de uso de las mismas que tienen un efecto terapéutico o cosmético de larga duración
EP2413947B1 (en) Methods and compositions for treating skin conditions associated with vascular hyper-reactivity
CN103096980B (zh) 皮肤抗衰老治疗
AU2010265888A1 (en) Albumin-free botulinum toxin formulations
US20150157728A1 (en) Stabilized and solubilized drug formulation for topical application and transdermal efficacy for cosmetic improvement and methods of formulation
CA3064070A1 (en) Methods of treatment for cervical dystonia
HK1240854A1 (zh) 可注射的肉毒杆菌毒素制剂
HK1256878B (en) Injectable botulinum toxin formulations
HK1162925A (en) Injectable botulinum toxin formulations

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20190322